AI-generated summary
This review systematically searched four databases for clinical and mechanistic studies of photobiomodulation therapy, a low-level light treatment. The authors report that effects on cellular energy, oxidative stress, and inflammation have been observed across several medical fields, but that clinical results remain inconsistent, with some equivocal or negative trial outcomes. They attribute this partly to non-standardized dosimetry and heterogeneous endpoints.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract notes non-standardized dosimetry, inconsistent energy delivery, heterogeneous study endpoints, and context-dependent, sometimes negative outcomes, and does not report the number of studies included.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Photobiomodulation therapy (PBMT) represents a rapidly expanding area of translational research that bridges photophysics, mitochondrial biology, and clinical rehabilitation. It leverages low-level light to modulate cellular bioenergetics, inflammatory signaling, and tissue repair processes across various medical disciplines.
Methods
A systematic literature search was conducted using Google Scholar, Scopus, PubMed, and Web of Science to identify recent clinical and mechanistic studies on PBMT. The gathered evidence was analyzed to evaluate the influence of PBMT on cytochrome c oxidase-mediated energy transduction, reactive oxygen species modulation, nitric oxide signaling, and cytokine regulation.
Results
Current findings indicate that PBMT exerts multifaceted effects on metabolism and immune homeostasis. Clinical applications have expanded from dermatology and wound healing to musculoskeletal, neurological, ophthalmic, and oncologic conditions. PBMT shows potential for symptom alleviation, accelerated recovery, and tissue protection under oxidative or inflammatory stress. However, translation from preclinical evidence to consistent clinical outcomes remains constrained by non-standardized dosimetry, inconsistent energy delivery, and heterogeneous study endpoints. Negative or equivocal outcomes in trials involving trained or low-stress cohorts highlight the context-dependent efficacy of PBMT. Immunoregulatory insights further reveal links between redox-sensitive transcriptional control and systemic cytokine balance.
Conclusions
By integrating mechanistic and clinical perspectives, this review positions PBMT as a promising yet incompletely optimized platform for mechanism-guided phototherapy. Future directions include biomarker-guided treatment monitoring, advanced device engineering, and personalized PBMT modeling through optical and metabolic profiling to achieve its full translational and therapeutic potential.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Reactive oxygen species, Cytochrome c oxidase, Wound healing, Nitric oxide, Phototherapy, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.